Article Details
Retrieved on: 2025-01-30 14:28:19
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson's disease drug, risvodetinib, and will now pause ...
Article found on: www.biopharma-reporter.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here